multiple myeloma mm has been the most intractable hematological disease for many yearsrecently basic and clinical research has advanced remarkably and a new therapeutic strategy has been establishedthe introduction of highdose melphalan with autologous stemcell transplantation and the availability of moleculartargeted novel agents such as immunomodulatory drugs and proteasome inhibitors have dramatically changed the treatment strategies for mmachievement of a high response rate resulted in the extension of overall survival but further research and the development of more multimodality therapeutic approaches is warranted to cure this disease